Ha Tay Pharmaceutical JSC (HNX:DHT)

Ha Tay Pharmaceutical JSC Revenue

Ha Tay Pharmaceutical JSC had revenue of 568.83B VND in the quarter ending March 31, 2026, with 14.68% growth. This brings the company's revenue in the last twelve months to 2.47T, up 19.17% year-over-year. In the year 2025, Ha Tay Pharmaceutical JSC had annual revenue of 2.40T with 15.13% growth.

• Revenue (ttm): 2.47T
• Revenue Growth: +19.17%
• P/S Ratio: 2.42
• Revenue / Employee: 4.22B
• Employees: 586
• Market Cap: 5.98T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.40T	315.69B	15.13%
Jan 1, 2025	2.09T	87.05B	4.35%
Jan 1, 2024	2.00T	161.91B	8.81%
Jan 1, 2023	1.84T	228.03B	14.17%
Jan 1, 2022	1.61T	-397.11B	-19.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error